Abbott Laboratories buy Citigroup Inc.
Start price
04.03.25
/
50%
€131.62
Target price
04.03.26
€151.81
Performance (%)
-18.90%
Price
18.12.25
€106.74
Summary
This prediction is currently active. The prediction for Abbott Laboratories disappoints with a performance of -18.90%. This prediction currently runs until 04.03.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | 1.638% | 1.638% |
| iShares Core DAX® | -0.793% | 4.201% |
| iShares Nasdaq 100 | -2.376% | 0.857% |
| iShares Nikkei 225® | -2.701% | -0.147% |
| iShares S&P 500 | -1.689% | 1.244% |
Comments by Citigroup_Inc_ for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Citigroup Inc. from $135.00 to $160.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€100.50
22.08.24
22.08.24
€114.22
22.08.25
22.08.25
12.26%
23.08.25
23.08.25
Abbott Laboratories
Start price
Target price
Perf. (%)
€96.77
22.05.24
22.05.24
€109.79
22.05.25
22.05.25
20.39%
23.05.25
23.05.25
Abbott Laboratories
Start price
Target price
Perf. (%)
€103.10
03.04.24
03.04.24
€118.21
03.04.25
03.04.25
14.47%
04.04.25
04.04.25
Abbott Laboratories
Start price
Target price
Perf. (%)
€102.48
25.01.24
25.01.24
€116.25
25.01.25
25.01.25
16.30%
26.01.25
26.01.25